Global Market Reach Inmunotek has established a presence in over 50 countries, providing opportunities to expand sales channels and collaborate with international distributors and healthcare providers interested in allergy, infectious disease, and cancer vaccines.

Innovation Awards Receiving the National Innovation Award highlights Inmunotek’s reputation for cutting-edge research and development, making it an attractive partner for healthcare institutions seeking innovative therapeutic solutions.

Product Development Focus Their ongoing development of bacterial vaccines like Uromune presents opportunities to introduce new products to clinics and hospitals specializing in allergy and immunotherapy treatments.

Regulatory Accreditation With GMP-certified manufacturing facilities in Madrid, Inmunotek is positioned to meet high standards for quality and compliance, facilitating entry into regulated markets and expanding sales efforts in healthcare sectors valuing quality assurance.

Growth Trajectory Recognized as one of Europe’s Long-Term Growth Champions, Inmunotek’s consistent growth signals stability and potential for long-term partnerships with pharmaceutical and healthcare companies seeking reliable suppliers of innovative vaccines and medical devices.